Clinical trials in Prague – page 77

Clinical trial activity in Praha includes research in advanced melanoma and diffuse large B-cell lymphoma, with a strong focus on improving cancer control and extending survival.

• Advanced melanoma
• Previously untreated diffuse large B-cell lymphoma
• Testing new treatment combinations
• Evaluating survival outcomes and disease progression

These studies are designed to refine how immunotherapy and other cancer treatments perform in everyday clinical care.

Research in cardiovascular diseases is centered on reducing major heart and vascular events, with trials looking at hypertension, atherosclerotic cardiovascular disease, and heart failure prevention.

• Hypertension
• Atherosclerotic cardiovascular disease
• Prevention of heart failure
• Lowering the risk of stroke and other vascular complications

Several studies aim to improve treatment effectiveness for patients at elevated cardiovascular risk.

Trials in the respiratory field focus on better symptom control and fewer flare-ups in chronic obstructive pulmonary disease, alongside ongoing work in infection-related lung illness.

• Chronic obstructive pulmonary disease
• Covid-19 in people at high risk of severe illness
• Testing new antiviral and anti-inflammatory approaches
• Reducing exacerbations and severe outcomes

These studies support more effective care for both chronic and acute respiratory conditions.

Dermatology research in Czechia includes several inflammatory skin disorders, with studies targeting itch, lesion control, and long-term disease management.

• Atopic dermatitis
• Moderate to severe plaque psoriasis
• Hidradenitis suppurativa
• Neurodermatitis and lichen simplex chronicus

The goal is to evaluate new therapies that may ease symptoms and improve quality of life.

Studies in immune-mediated disease are exploring treatments that can calm abnormal inflammation while maintaining safety and tolerability.

• Psoriatic arthritis
• Atopic dermatitis
• Psoriasis-related inflammatory conditions
• Assessing immune-targeted therapy effectiveness

These trials aim to improve control of chronic immune-driven disease burden.

Neurology-related research focuses on agitation in Alzheimer's disease dementia, with efforts to better manage behavioral symptoms that affect patients and caregivers.

• Agitation in Alzheimer's disease dementia
• Symptom relief and behavioral improvement
• Evaluating new therapeutic options

These studies may help support more practical care for people living with dementia.

Metabolic research in Praha includes trials for overweight, obesity, and related conditions, often linked with cardiovascular risk.

• Overweight and obesity
• Hypertension with obesity
• Type 2 diabetes-related weight management
• Supporting weight loss and cardiometabolic health

These studies are testing approaches that may help reduce long-term health risks tied to excess weight.

In the area of virus diseases, research is centered on improving treatment options for people with COVID-19 who are at higher risk of becoming seriously ill.

• COVID-19 at high risk of progression
• Reducing illness severity
• Testing antiviral treatment effectiveness

The main aim is to help prevent worsening disease and support faster recovery.